- Previous Close
0.0130 - Open
0.0130 - Bid 0.0130 x --
- Ask 0.0140 x --
- Day's Range
0.0130 - 0.0130 - 52 Week Range
0.0080 - 0.0210 - Volume
15,800 - Avg. Volume
658 - Market Cap (intraday)
2.172M - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.
hexima.com.auRecent News: HXL.AX
View MorePerformance Overview: HXL.AX
Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HXL.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HXL.AX
View MoreValuation Measures
Market Cap
2.17M
Enterprise Value
-54.70k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.07
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.51%
Return on Equity (ttm)
-38.89%
Revenue (ttm)
61.67k
Net Income Avi to Common (ttm)
-933.87k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.23M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
643.74k